Coronary Artery Calcium Score and Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia Patients Undergoing Standard Lipid Lowering Therapy

被引：0
|
作者：
Miname, Marcio [1 ]
Bittencourt, Marcio S. [2 ]
Moraes, Sergio R. [1 ]
Alves, Romulo, I [1 ]
Silva, Pamela R. [1 ]
Jannes, Cinthia E. [1 ]
Pereira, Alexandre C. [1 ]
Nasir, Khurram [3 ]
Santos, Raul D. [1 ]
机构：
[1] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil
[2] FICSAE, Med, Sao Paulo, Brazil
[3] Yale Sch Med, Ctr Outcomes Res & Evaluat, New Haven, CT USA
来源：
CIRCULATION | 2018年 / 138卷
关键词：
Calcification; Lipids;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11937
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Lipid-lowering therapy for patients with or at risk of coronary artery disease
    Kjekshus, J
    Pedersen, TR
    Tobert, JA
    CURRENT OPINION IN CARDIOLOGY, 1996, 11 (04) : 418 - 427
  • [32] Reduction of cardiovascular events with the use of lipid-lowering medication in patients with familial hypercholesterolemia or severe primary hypercholesterolemia: A systematic review
    Masson, Walter
    Corral, Pablo
    Barbagelata, Leandro
    Lavalle-Cobo, Augusto
    Nogueira, Juan P.
    Siniawski, Daniel
    Ray, Kausik K.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (05) : 562 - 573
  • [33] Lipid-lowering therapy and risk of coronary events
    Blakely, JA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16): : 2070 - 2071
  • [34] CORONARY ARTERY CALCIUM IN PATIENTS WITH MONOGENIC FAMILIAL HYPERCHOLESTEROLEMIA VS POLYGENIC HYPERCHOLESTEROLEMIA
    Ernaga Lorea, Ander
    Martinez De Esteban, Juan Pablo
    Apellaniz-Ruiz, Maria
    Arasanz Armengol, Monica
    Garcia Torres, Javier
    Anda Apinaniz, Emma
    ATHEROSCLEROSIS, 2024, 395
  • [35] APPLICABILITY OF THE CARDIOVASCULAR RISK PREDICTOR "SCORE" TO PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Descamps, O.
    Humphries, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [36] IMPACT OF DIABETES ON CORONARY SEVERITY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Liu, M. -M.
    Li, J. -J.
    ATHEROSCLEROSIS, 2021, 331 : E168 - E168
  • [37] IMPACT OF DIABETES ON CORONARY SEVERITY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Liu, Mingming
    Li, Jian-Jun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1561 - 1561
  • [38] Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia
    Antonio Gallo
    Reed Mszar
    Marcio Hiroshi Miname
    Current Atherosclerosis Reports, 2022, 24 : 407 - 418
  • [39] Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia
    Gallo, Antonio
    Mszar, Reed
    Miname, Marcio Hiroshi
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (06) : 407 - 418
  • [40] POLYGENIC RISK FOR FUTURE CORONARY ARTERY DISEASE EVENTS IN FAMILIAL HYPERCHOLESTEROLEMIA
    Reeskamp, L. F.
    Shim, I.
    Dron, J.
    Ibrahim, S.
    Tromp, T. R.
    Patel, A. P.
    Hutten, B. A.
    Stroes, E. S.
    Hovingh, G. K.
    Khera, A. V.
    ATHEROSCLEROSIS, 2022, 355 : E231 - E232
12345